Today we're speaking with Keren Leshem. Keren Leshem is the CEO of OCON Healthcare that focuses on women's health, primarily creating high-quality intrauterine drug delivery solutions. OCON is innovating in areas that have not been touched for three decades. Furthermore, Keren is very active in the FemTech ecosystem as a whole. 

00:55 What was your journey that brought you into this market of pharma, MedTech and drug delivery? And why did it begin abroad?

 02:59 What does OCON do?

06:31 Why did you build OCON with a female majority? Is there any difference in managing a company that is predominantly female on a day-to-day basis?

09:23 Do you think that you need to be a woman to lead a FemTech company?

10:40 What are seeing is changing in the FemTech space? What do you expect will happen looking forward?

16:47 When did you feel that OCON’s solution is really unique? 

22:44 What did you find when you joined the company in 2018? And what did you do to turn it around?

26:40 You mentioned you found a way to recruit patients inexpensively during COVID. Can you tell us a little bit about how you did this?

33:23 Do you do any promotion to the end-user using social media?

34:49 Where does the world of direct-to-consumer or at least consumer-centric marketing live in your vision going forward for OCON?

 38:40 What would you say to those people that say that using social media and LinkedIn is only applicable to MedTech companies that are already in the market?

42:28 What tips you would give to up-and-coming CEOs in the MedTech space if they can contact you for advice and mentorship?

46:51 Could you elaborate a little bit on your volunteer work with Michla’la? How did you get involved with that?